小细胞肺癌
- 化疗
-
- 抗代谢类
- Gemcitabine
- Methotrexate
-
- 拓扑异构酶抑制剂
- Irinotecan
- Etoposide
- Topotecan
- Doxorubicin
-
- RNA聚合酶抑制剂
- Lurbinectedin
-
- 骨髓保护剂
- Trilaciclib
- 免疫检查点抑制剂
-
- CTLA-4
- Ipilimumab
- Tremelimumab
- 抗血管生成
- Vandetanib
- Bevacizumab
- Ramucirumab
- Apatinib
- Sunitinib
- Nintedanib
- Pazopanib
- Sorafenib
- Cediranib
- ADC
-
- TROP2
- Sacituzumab-govitecan
- 相关化合物库
- FDA-approved Anticancer Drug Library
- Anti-cancer Compound Library
- Anti-cancer Compound Library-Ⅱ
- Anti-cancer Metabolism Compound Library
- Cambridge Cancer Compound Library
- FDA-approved Drug Library
- 靶向疗法
-
- mTOR
- Everolimus
-
- Bcl-2
- Venetoclax
-
- c-KIT
- Imatinib
-
- Aurora
- Barasertib
-
- DLL3
- Rovalpituzumab
-
- Wee1
- Adavosertib
